Have a Claim?

Click here for a confidential contact or call:


April 20, 2017

Posted  May 11, 2017

Illinois-based drugstore giant Walgreen Co. agreed to pay $9.86 million to resolve allegations it violated the False Claims Act by submitting claims for reimbursement to California’s Medi-Cal program that were not supported by applicable diagnosis and documentation requirements. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a former Walgreens pharmacist and a former pharmacy technician. They will receive a whistleblower award of roughly $2.3 million from the proceeds of the government’s recovery. DOJ (EDCA)

Tagged in: FCA Federal, Medical Billing Fraud, Pharma Fraud, Whistleblower Case,